Milan

• Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised
  2024-512754-16-00 5 Prostate cancer
• MELFLUFEN FOR ELDERLY PATIENTS WITH RELAPSED MYELOMA Not authorised
  2024-514652-33-00 4 Relapsed Multiple Myeloma
• A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE Not authorised
  2024-514794-22-01 4 Eosinophilic granulomatosis with polyangiitis (EGPA)
• A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with … Not authorised
  2024-515199-10-00 4 Retinitis Pigmentosa
• Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoi … Not authorised
  2024-515333-14-00 5 Patients scheduled for major surgery for oncologic indication
• A multicentre randomised study on percutaneous stellate ganglion block as first-line treatment in patients with electrical storm: the STAR 2 … Not authorised
  2024-520387-34-00 6 electrical storm
• A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr … Not authorised
  2025-523820-26-00 5 Growth Hormone Deficiency (GHD)
• A phase 2b, single-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of oral Ladarixin in associa … Not authorised
  2025-524298-18-00 4 new-onset autoimmune type 1 diabetes
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 5 Ulcerative colitis
• Clinical and ultrasound assessment of the therapeutic response to ixekizumab in psoriatic arthritis dactlylitis; a multicentre, parallel-gro … Pending
  2022-503119-40-00 5 psoriatic arthritis (PsA)
• MITO CERV4: Single arm phase II study on Pembrolizumab in pre neoplastic high grade HPV-related vulvar and cervical lesions Pending
  2023-504035-40-00 4 Patients with pre neoplastic high grade HPV-related vulvar and cervica
• Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Pending
  2023-505750-17-00 4 Neovascular age-related macular degeneration
• Botulinumtoxin type A for treatment of Chronic Pelvic Pain Syndrome (CPPS): a phase 3 randomized, double blind, placebo-controlled, multi-ce … Pending
  2023-506372-27-00 5 Adult patients, male or female, with chronic pelvic pain syndrome (CPP
• ATA-200 gene therapy trial in patients with LGMDR5 Pending
  2023-506440-16-00 7 limb-girdle muscular dystrophy type R5 (previously named LGMD2C)
• A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sa … Pending
  2023-507590-18-00 4 Pulmonary sarcoidosis with or without extrapulmonary manifestations
• A Study to Learn About the Study Medicine Called Aztreonam-Avibactam in Neonates and Infants Less Than 9 Months of Age With Suspected or Con … Pending
  2023-507757-15-01 4 Sepsis
• A study to investigate efficacy of RP2 with nivolumab compared to ipilimumab with nivolumab in adult patients with advanced uveal melanoma n … Pending
  2023-508784-68-00 10 metastatic uveal melanoma
• Perioperative Therapy with Durvalumab Plus Tremelimumab for Patients with Resectable Hepatocellular Carcinoma (HCC) - A Phase II Trial (NEOT … Pending
  2023-508863-59-01 4 Resectable Hepatocellular Carcinoma
• A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending
  2023-509176-42-00 11 Obesity and T2D
• Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Pending
  2024-511054-50-00 10 HIV-1 Infection
• A Study of Anti-CD19 CAR T-cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis Pending
  2024-511168-10-00 4 Primary or Secondary Progressive Multiple Sclerosis
• Activity of Pembrolizumab plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma (REPRINT trial) Pending
  2024-511587-93-00 4 Medullary Renal cell Carcinoma
• An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants with Duchenne Muscular Dystrophy Pending
  2024-511656-41-00 4 Duchenne Muscular Dystrophy

Showing 25–48 of 2,361 trials